Novelcare
ActiveEmpowering every doctor and every patient to participate in research
This company has previously operated under “Recomp”, “Resync”, “Workpage”, “Resync”, “SelectIQ”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Novelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.
Founders · 2
Ethan is the co-founder and CEO of SelectIQ. Prior to SelectIQ, Ethan was a product strategist at Palantir where he led product development into multiple new verticals, most recently helping to build Palantir's nascent life sciences division. Ethan is a product designer and software engineer by training, having *almost* graduated from Rensselaer Polytechnic Institute.
Jason is the co-founder and CTO of SelectIQ. Prior to SelectIQ, Jason worked at Palantir on life sciences software and led Palantir's Data Governance product team. Previously, he co-founded Skylight, an NYC real estate app acquired by Common Living. He's also a 2015 Thiel Fellow.
Related startups
Accelerate clinical trials with real-time, actionable insights
AI-powered Patient Identification for Clinical Trials
